Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance ; volume:21 ; number:1 ; day:7 ; month:11 ; year:2023 ; pages:1-19 ; date:12.2023
Journal of translational medicine ; 21, Heft 1 (7.11.2023), 1-19, 12.2023
- Urheber
-
Zheng, Kun
Hai, Youlong
Xi, Yue
Zhang, Yukun
Liu, Zheqi
Chen, Wantao
Hu, Xiaoyong
Zou, Xin
Hao, Jie
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-023-04683-6
- URN
-
urn:nbn:de:101:1-2024012409213593150296
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zheng, Kun
- Hai, Youlong
- Xi, Yue
- Zhang, Yukun
- Liu, Zheqi
- Chen, Wantao
- Hu, Xiaoyong
- Zou, Xin
- Hao, Jie
- SpringerLink (Online service)
Ähnliche Objekte (12)
A multi-omics supervised autoencoder for pan-cancer clinical outcome endpoints prediction
Multiomics biomarkers were not superior to clinical variables for pan-cancer screening
Pan-cancer and multi-omics analyses revealed the diagnostic and prognostic value of BAZ2A in liver cancer
Lactylome Analysis Unveils Lactylation‐Dependent Mechanisms of Stemness Remodeling in the Liver Cancer Stem Cells
Pan-cancer analysis from multi-omics data reveals AAMP as an unfavourable prognostic marker
Multi-omics pan-cancer analyses identify MCM4 as a promising prognostic and diagnostic biomarker
Multi-omics pan-cancer study of SPTBN2 and its value as a potential therapeutic target in pancreatic cancer
Machine learning multi-omics analysis reveals cancer driver dysregulation in pan-cancer cell lines compared to primary tumors
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Spatial multiomics reveals a subpopulation of fibroblasts associated with cancer stemness in human hepatocellular carcinoma
Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types
A multi-omics supervised autoencoder for pan-cancer clinical outcome endpoints prediction
Multiomics biomarkers were not superior to clinical variables for pan-cancer screening
Pan-cancer and multi-omics analyses revealed the diagnostic and prognostic value of BAZ2A in liver cancer
Lactylome Analysis Unveils Lactylation‐Dependent Mechanisms of Stemness Remodeling in the Liver Cancer Stem Cells
Pan-cancer analysis from multi-omics data reveals AAMP as an unfavourable prognostic marker
Multi-omics pan-cancer analyses identify MCM4 as a promising prognostic and diagnostic biomarker
Multi-omics pan-cancer study of SPTBN2 and its value as a potential therapeutic target in pancreatic cancer
Machine learning multi-omics analysis reveals cancer driver dysregulation in pan-cancer cell lines compared to primary tumors
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Spatial multiomics reveals a subpopulation of fibroblasts associated with cancer stemness in human hepatocellular carcinoma
Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types
A multi-omics supervised autoencoder for pan-cancer clinical outcome endpoints prediction
Multiomics biomarkers were not superior to clinical variables for pan-cancer screening
Pan-cancer and multi-omics analyses revealed the diagnostic and prognostic value of BAZ2A in liver cancer
Lactylome Analysis Unveils Lactylation‐Dependent Mechanisms of Stemness Remodeling in the Liver Cancer Stem Cells
Pan-cancer analysis from multi-omics data reveals AAMP as an unfavourable prognostic marker
Multi-omics pan-cancer analyses identify MCM4 as a promising prognostic and diagnostic biomarker
Multi-omics pan-cancer study of SPTBN2 and its value as a potential therapeutic target in pancreatic cancer
Machine learning multi-omics analysis reveals cancer driver dysregulation in pan-cancer cell lines compared to primary tumors
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Spatial multiomics reveals a subpopulation of fibroblasts associated with cancer stemness in human hepatocellular carcinoma